Skip to main content
    C

    Carlsmed, Inc. (CARL)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $17.74
    +0.39 (+2.25%)

    Market Cap: $475.46M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Carlsmed, Inc. (CARL) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Carlsmed (CARL) has a market cap of $475.46M and an enterprise value of $454.92M. Its share count is up 29.51% from a year earlier. Revenue grew 60.38% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 4.32% below the market cap, as cash exceeds debt.

    Market Cap$475.46M
    Enterprise Value$454.92M
    Latest price (Nov 17, 2026)$17.74

    Key Dates

    The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 24, 2027 (expected)
    Last Earnings DateNov 10, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.41% in the quarter ended Sep 30, 2026 and grew 143.90% a year over 2 years.

    Shares Outstanding27.30M
    Shares Change (YoY)+29.51%
    Shares Change (QoQ)+0.41%
    Share Count Growth (2Y CAGR)+143.90%

    Valuation Ratios

    Sales and book value multiples are 6.7x and 6.4x.

    P/S Ratio6.7x
    Forward P/S6.0x
    P/B Ratio6.4x

    Price Statistics

    The stock is up 35.32% over 52 weeks and trades 17.87% above its 50-day average.

    Beta (1Y)1.55
    52-Week Change+35.32%
    1-Month Change+29.87%
    3-Month Change+14.30%
    6-Month Change+57.13%
    Total Return (1Y)+35.32%
    Return vs SPY (1Y)+33.26%
    Max Drawdown (1Y)-48.03%
    Sharpe Ratio (1Y)0.50
    Correlation with SPY (1Y)0.29
    50-Day Average$15.05
    200-Day Average$12.60
    52-Week Range$8.50 to $19.15
    RSI (14 Days)60.0
    Average Volume (20 Days)161.13K

    Financial Position

    Current assets cover 5.79x current liabilities, and total debt is 0.20x shareholder equity.

    Current Ratio5.79x
    Quick Ratio5.62x
    Debt / Equity0.20x
    Interest Coverage-33.33x

    Returns and Efficiency

    Return on invested capital is -36.71% and return on equity is -52.94% over the last 12 months.

    Return on Equity (ROE)-52.94%
    Return on Assets (ROA)-34.76%
    Return on Invested Capital (ROIC)-36.71%
    Asset Turnover0.57x
    Inventory Turnover6.28x
    Receivables Turnover4.68x
    Cash Conversion Cycle59 days

    Scores

    CARL has an Altman Z-Score of 6.05, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score6.05
    Altman Z ZoneSafe
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $71.78M over the last 12 months.

    Revenue$71.78M
    Revenue Growth (YoY)+60.38%
    Gross Profit$55.24M
    Operating Income-$48.05M
    Pretax Income-$46.38M
    Net Income-$40.65M
    Reported EPS (TTM)-$1.31

    Trailing 12 months through Sep 30, 2026.

    Balance Sheet

    Shareholder equity funds 65.65% of the $115.27M in total assets.

    Cash and Equivalents$35.95M
    Total Debt$15.40M
    Net Cash$20.55M
    Net Cash Per Share$0.75
    Working Capital$87.32M
    Shareholder Equity$75.67M
    Book Value Per Share$2.77
    Total Assets$115.27M
    Total Liabilities$39.60M

    Balance sheet as of Sep 30, 2026.

    Cash Flow

    After $1.79M of capital spending, operating cash flow left -$36.15M of free cash flow.

    Operating Cash Flow-$34.36M
    Capital Expenditures$1.79M
    Free Cash Flow-$36.15M
    FCF Per Share-$1.32
    Depreciation and Amortization$562.00K

    Trailing 12 months through Sep 30, 2026.

    Margins

    The operating margin is -66.95%.

    Gross Margin76.96%
    Operating Margin-66.95%
    Pretax Margin-64.61%
    Net Margin-56.63%
    FCF Margin-50.36%

    Dividends and Yields

    CARL does not pay a dividend. Its free cash flow yield is -7.46%.

    FCF Yield-7.46%
    Buyback Yield-0.04%
    Shareholder Yield-0.04%

    Peer Position

    Against 11 similar companies, CARL has the 2nd highest P/S.

    P/S Ratio6.7x vs 2.5x median
    ROIC-36.71% vs 2.72% median
    Revenue Growth (Trailing 4 Quarters, YoY)+60.38% vs +11.38% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About CARL

    What is CARL's market cap?

    Carlsmed has a market cap of $475.46M. Its enterprise value, which adds debt and subtracts cash, is $454.92M.

    How many shares of CARL are outstanding?

    Carlsmed has 27.30M shares outstanding. The count is up 29.51% from a year earlier.

    Does CARL pay a dividend?

    No. Carlsmed does not pay a dividend.

    How much debt does CARL have?

    Carlsmed has $15.40M of total debt and $35.95M of cash and equivalents, a net cash position of $20.55M.